CREDENCE: A silver lining in the dark cloud of diabetic nephropathy

[...]SGLT2 inhibitors have a strong effect in reducing the risk of deteriorating heart failure, which is closely associated with advanced diabetic nephropathy. A recent study of patients with heart failure and a reduced ejection fraction showed that the risk of deteriorating heart failure or death f...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of diabetes investigation Vol. 11; no. 3; pp. 527 - 529
Main Authors:	Hanai, Ko, Babazono, Tetsuya
Format:	Journal Article
Language:	English
Published:	Japan John Wiley & Sons, Inc 01.05.2020 John Wiley and Sons Inc Wiley
Subjects:	Antidiabetics Blood pressure Canagliflozin - therapeutic use Cardiovascular disease Clinical trials Commentaries Confidence intervals Congestive heart failure Diabetes Diabetes mellitus Diabetic Nephropathies - diagnosis Diabetic Nephropathies - drug therapy Diabetic Nephropathies - epidemiology Diabetic nephropathy Enzymes Glucose Heart failure Humans Kidney diseases Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - prevention & control Nephropathy Peptides Randomized Controlled Trials as Topic - methods Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
ISSN:	2040-1116, 2040-1124, 2040-1124
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!